Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Liver-Enriched miR-122 in COVID-19 Patients: A Longitudinal Real-Life Study.

International journal of molecular sciences·2026
Same author

Beyond Foodborne HAV: Sexual Transmission Drives a New Wave of Cases in Romania.

Viruses·2026
Same author

Maternal Antiretroviral Use and the Risk of Prematurity and Low Birth Weight in Perinatally HIV-Exposed Children-7 Years' Experience in Two Romanian Centers.

Medicina (Kaunas, Lithuania)·2026
Same author

Association of Herpes Virus Type 1, Cytomegalo Virus and Epstein-Barr Virus to the Pathogenesis of Peri-Implantitis: A Cross-Sectional Study.

Dentistry journal·2025
Same author

Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.

International journal of molecular sciences·2025
Same author

The Impact of the Microbiota on the Immune Response Modulation in Colorectal Cancer.

Biomolecules·2025
Same journal

Precision Proteomic Profiling of Systemic Lupus Erythematosus-Correlating Disease Activity and Complement Levels with Clinical Phenotypes.

Biomedicines·2026
Same journal

The Role of Salivary Microbiota in Pancreatic Cancer: From Screening to Tumor Progression and Treatment Response.

Biomedicines·2026
Same journal

Diagnostic Utility of Surface Electromyography for Identifying Muscles Affected by Myofascial Trigger Points: A Scoping Review.

Biomedicines·2026
Same journal

Performance Assessment of a Locally Semi-Automated NGS-Based Workflow for Homologous Recombination Deficiency Testing in High-Grade Serous Ovarian Carcinoma.

Biomedicines·2026
Same journal

Coupling and Uncoupling Pleiotropy Between Hypertension and Type 2 Diabetes Contribute to Exploring Potential Heterogeneity in Cardiovascular Risk in East Asian Population.

Biomedicines·2026
Same journal

Maternal Response to Therapeutic Plasma Exchange in Early Gestation: A Case Series of Thrombotic Microangiopathies and Neurological Disorders.

Biomedicines·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K

HIV-HBV Coinfection-Current Challenges for Virologic Monitoring.

Simona Ruta1,2, Laura Grecu2, Diana Iacob3

  • 1Virology Discipline, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Biomedicines
|May 27, 2023
PubMed
Summary
This summary is machine-generated.

HIV and HBV coinfection accelerates liver disease progression and increases mortality. Novel biomarkers are crucial for monitoring treatment effectiveness and predicting outcomes in coinfected patients.

Keywords:
HIV-HBV co-infectionRT-PCRantiretroviral treatmentbiomarkersddPCRpathogenesispublic health

More Related Videos

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.6K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.5K

Related Experiment Videos

Last Updated: Jun 21, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.6K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.5K

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • HIV-HBV coinfection leads to severe liver disease, including fibrosis and hepatocellular carcinoma (HCC).
  • Combined viral actions and host immune responses drive accelerated liver injury.
  • Current antiviral therapies face challenges like delayed initiation and accessibility issues.

Purpose of the Study:

  • To review mechanisms of liver injury in HIV-HBV coinfected individuals.
  • To identify novel biomarkers for monitoring treatment in coinfected patients.
  • To explore biomarkers for viral suppression, liver fibrosis, and oncogenesis prediction.

Main Methods:

  • Literature review of clinical studies and research on HIV-HBV coinfection.
  • Analysis of mechanisms contributing to liver damage.
  • Identification and categorization of potential biomarkers.

Main Results:

  • HIV-HBV coinfection significantly increases liver-related complications compared to mono-infections.
  • Accelerated liver fibrosis and higher HCC incidence are observed.
  • Effective antiviral therapy exists but faces implementation barriers.

Conclusions:

  • Understanding liver injury mechanisms is key for managing HIV-HBV coinfection.
  • Novel biomarkers are essential for optimizing treatment monitoring and patient outcomes.
  • Biomarkers for viral suppression, fibrosis, and HCC prediction require further validation.